The election results caused shares of U.S. pharmaceutical companies to rise, as the divided Congress is unlikely to reduce drug prices. Shares of Pfizer and AbbVie were up more than 3 percent on Nov. 7, while shares of Merck and Bristol-Myers Squibb were up more than 2 percent.
The election results and the legislative deadlock that is expected over the next two years also caused shares of major health insurers to jump.
Shares of Humana hit an all-time high Nov. 7 of $354.33, and shares of Anthem and UnitedHealth also hit records, according to Reuters.
More articles on healthcare finance:
The rural hospital closure crisis: 9 things to know
CMS overhauls home health payment model: 5 things to know
Tenet’s net loss shrinks amid $250M cost-cutting drive
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.